Coronavirus

Bamlanivimab, Benzinga, Biotech, Coronavirus, COVID-19, General, Health Care, LLY, News, REGN, the National Institute of Allergy and Infectious Diseases, US5324571083, US75886F1075

NIAID Study Finds Eli Lilly’s Antibody Drug Unhelpful For Hospitalized COVID-19 Patients

Eli Lilly and Company (NYSE: LLY) said Monday that a trial of its antibody treatment for use in hospitalized COVID-19 patients has come to an end as the treatment is unlikely to help such patients. 
read more

Coronavirus, News

Israel to Begin Clinical Trials of COVID-19 Vaccine as Early as Nov. 1

The governmental Israel Institute for Biological Research (IIBR) has approval from the Israeli Health Ministry and the Helsinki Committee to begin testing its SARS-CoV-2 vaccine, BriLife, on Nov. 1. The IIBR has prepared 25,000 doses and has recruited the first volunteers in an 80-person clinical trial, 40 at Hadassah University Medical Center in Jerusalem and […]

The post Israel to Begin Clinical Trials of COVID-19 Vaccine as Early as Nov. 1 appeared first on Jewish Journal.

Commentary, Coronavirus, Editor's Note, Featured, jewish education, Opinion, synagogues

In a Post-Pandemic World, We’ll Need to Reimagine Jewish Spaces

Instead of bemoaning our fate, we can use this unprecedented moment to develop new, more flexible models that better fit our changing world. A good place to start is the creation of multi-use spaces that would increase communal engagement while making Jewish education more affordable.

The post In a Post-Pandemic World, We’ll Need to Reimagine Jewish Spaces appeared first on Jewish Journal.

1 2 3 … 389